These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23701927)

  • 1. Phenomenon of elongated struts: is optical coherence tomography accurate enough to analyze scaffold area?
    Kharlamov AN
    Int J Cardiol; 2013 Oct; 168(4):4280-4. PubMed ID: 23701927
    [No Abstract]   [Full Text] [Related]  

  • 2. Everolimus-eluting bioresorbable vascular scaffold implantation in Kawasaki disease: serial OCT observation.
    Vogiatzi G; Toutouzas K; Karanasos A; Synetos A; Latsios G; Tsiamis E; Tousoulis D
    Hellenic J Cardiol; 2018; 59(6):358-359. PubMed ID: 29307692
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis.
    Sheehy A; Gutiérrez-Chico JL; Diletti R; Oberhauser JP; Glauser T; Harrington J; Kossuth MB; Rapoza RJ; Onuma Y; Serruys PW
    EuroIntervention; 2012 Feb; 7(10):1227-35. PubMed ID: 22222916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edge Vascular Response After Resorption of the Everolimus-Eluting Bioresorbable Vascular Scaffold　- A 5-Year Serial Optical Coherence Tomography Study.
    Tateishi H; Suwannasom P; Sotomi Y; Nakatani S; Ishibashi Y; Tenekecioglu E; Abdelghani M; Cavalcante R; Zeng Y; Grundeken MJ; Albuquerque FN; Veldhof S; Onuma Y; Serruys PW;
    Circ J; 2016 Apr; 80(5):1131-41. PubMed ID: 26936236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial.
    Onuma Y; Serruys PW; Perkins LE; Okamura T; Gonzalo N; García-García HM; Regar E; Kamberi M; Powers JC; Rapoza R; van Beusekom H; van der Giessen W; Virmani R
    Circulation; 2010 Nov; 122(22):2288-300. PubMed ID: 20975003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Coherence Tomography of Magnesium Bioresorbable Scaffold Restenosis.
    García-Blas S; Miñana G; Sanchis J
    Rev Esp Cardiol (Engl Ed); 2018 Dec; 71(12):1069. PubMed ID: 29223376
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular flashlight. The fate of bioresorbable struts located at a side branch ostium: serial three-dimensional optical coherence tomography assessment.
    Okamura T; Serruys PW; Regar E
    Eur Heart J; 2010 Sep; 31(17):2179. PubMed ID: 20513731
    [No Abstract]   [Full Text] [Related]  

  • 8. Follow-up evaluation of unapposed bioresorbable vascular scaffold at a coronary bifurcation using optical coherence tomography.
    Danson E; Bhindi R; Hansen P
    Int J Cardiol; 2014 Dec; 177(2):e84-6. PubMed ID: 25456696
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial experience of percutaneous coronary intervention in bifurcations with bioresorbable vascular scaffolds using different techniques--insights from optical coherence tomography.
    Attizzani GF; Ohno Y; Capranzano P; La Manna A; Francaviglia B; Grasso C; Sgroi C; Tamburino C; Longo G; Fujino Y; Capodanno D; Tamburino C
    Int J Cardiol; 2013 Dec; 170(2):e33-5. PubMed ID: 24210418
    [No Abstract]   [Full Text] [Related]  

  • 10. Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts.
    Francaviglia B; Capranzano P; Capodanno D; Barbanti M; Tamburino CI; Buccheri S; Tamburino C
    Can J Cardiol; 2017 Jul; 33(7):951.e5-951.e6. PubMed ID: 28579161
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography.
    Gutiérrez-Chico JL; Regar E; Nüesch E; Okamura T; Wykrzykowska J; di Mario C; Windecker S; van Es GA; Gobbens P; Jüni P; Serruys PW
    Circulation; 2011 Aug; 124(5):612-23. PubMed ID: 21768536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography.
    Tada T; Byrne RA; Schuster T; Cuni R; Kitabata H; Tiroch K; Dirninger A; Gratze F; Kaspar K; Zenker G; Joner M; Schömig A; Kastrati A
    Cardiovasc Revasc Med; 2013; 14(2):84-9. PubMed ID: 23352095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography.
    Yao ZH; Matsubara T; Inada T; Suzuki Y; Suzuki T
    Chin Med J (Engl); 2008 Mar; 121(6):503-7. PubMed ID: 18364133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early coverage of Bioabsorbable Scaffold after STEMI analysed by 2D and 3D optical coherence tomography.
    Foin N; Ghione M; Mattesini A; Dall'Ara G; Davies JE; Di Mario C
    Cardiovasc Revasc Med; 2013; 14(6):363-4. PubMed ID: 24075359
    [No Abstract]   [Full Text] [Related]  

  • 15. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.
    Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
    Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
    Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of wall shear stress with long-term vascular healing response following bioresorbable vascular scaffold implantation.
    Karanasos A; Schuurbiers JC; Garcia-Garcia HM; Simsek C; Onuma Y; Serruys PW; Zijlstra F; van Geuns RJ; Regar E; Wentzel JJ
    Int J Cardiol; 2015 Jul; 191():279-83. PubMed ID: 25981369
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist?
    Takano M; Yamamoto M; Inami S; Murakami D; Seimiya K; Ohba T; Seino Y; Mizuno K
    J Am Coll Cardiol; 2008 Mar; 51(9):968-9. PubMed ID: 18308167
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes.
    Serruys PW; Onuma Y; Dudek D; Smits PC; Koolen J; Chevalier B; de Bruyne B; Thuesen L; McClean D; van Geuns RJ; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Sudhir K; Garcia-Garcia HM; Ormiston JA
    J Am Coll Cardiol; 2011 Oct; 58(15):1578-88. PubMed ID: 21958884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.
    Gomez-Lara J; Diletti R; Brugaletta S; Onuma Y; Farooq V; Thuesen L; McClean D; Koolen J; Ormiston JA; Windecker S; Whitbourn R; Dudek D; Dorange C; Veldhof S; Rapoza R; Regar E; Garcia-Garcia HM; Serruys PW
    EuroIntervention; 2012 Jun; 8(2):214-24. PubMed ID: 22030265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.